VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $116,178,000 | +34.8% | 4,999,064 | -7.7% | 4.34% | +20.7% |
| Q1 2018 | $86,192,000 | -38.5% | 5,414,064 | -20.1% | 3.59% | -39.8% |
| Q4 2017 | $140,228,000 | +13.6% | 6,778,159 | -21.3% | 5.97% | +12.4% |
| Q3 2017 | $123,423,000 | -18.4% | 8,612,913 | -1.5% | 5.31% | -13.5% |
| Q2 2017 | $151,220,000 | +90.3% | 8,741,048 | +21.3% | 6.13% | +75.4% |
| Q1 2017 | $79,479,000 | +12.7% | 7,205,675 | +48.4% | 3.50% | +13.1% |
| Q4 2016 | $70,502,000 | +25.3% | 4,855,500 | +111.9% | 3.09% | +34.2% |
| Q3 2016 | $56,254,000 | +39.2% | 2,291,400 | +14.2% | 2.30% | +27.5% |
| Q2 2016 | $40,407,000 | -2.8% | 2,006,300 | +26.9% | 1.81% | +12.9% |
| Q1 2016 | $41,579,000 | – | 1,580,950 | – | 1.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |